How many insider trades does FilingIQ track for CLRB?

FilingIQ tracks 89 Form 4 insider transactions for CLRB (Cellectar Biosciences, Inc.), covering filings from Jun 9, 2015 onwards. 4 of those were filed in the last 90 days.

Are CLRB insiders net buyers or net sellers?

Across the full Form 4 history for CLRB, 38 transactions (43%) were open-market purchases and 28 (31%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CLRB insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CLRB in?

Cellectar Biosciences, Inc. (CLRB) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $14.39M.

CLRB insider trading

NasdaqCM Healthcare

Cellectar Biosciences, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

43% / 31%

Market cap

$14.39M

About Cellectar Biosciences, Inc.

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States. The company's lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer. It also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChem Bio. Cellectar Biosciences, Inc. was founded in 2002 and is headquartered in Florham Park, New Jersey.

Company website: www.cellectar.com

CLRB insider activity at a glance

FilingIQ has scored 89 insider transactions for CLRB since Jun 9, 2015. The most recent filing in our index is dated May 7, 2026.

Across the full history, 38 open-market purchases and 28 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CLRB insider trades is 55.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CLRB trades on FilingIQ Raw filings on SEC EDGAR

Latest CLRB Form 4 filings

CARUSO JAMES V Chief Executive Officer

P May 7, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading CLRB

CARUSO JAMES V

2 trades · score 76.0

Frequently asked

How many insider trades does FilingIQ track for CLRB?: FilingIQ tracks 89 Form 4 insider transactions for CLRB (Cellectar Biosciences, Inc.), covering filings from Jun 9, 2015 onwards. 4 of those were filed in the last 90 days.
Are CLRB insiders net buyers or net sellers?: Across the full Form 4 history for CLRB, 38 transactions (43%) were open-market purchases and 28 (31%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CLRB insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CLRB in?: Cellectar Biosciences, Inc. (CLRB) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $14.39M.

Methodology & sources

Every CLRB insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.